The Sky Shop For Hope
$50 Mystery Box
$50 Mystery Box
Couldn't load pickup availability
The $50 Mystery Box is the perfect way to give back while receiving a surprise you’ll love. Each box contains one carefully selected item from the Cure Cancer Shop, making every delivery exciting and unique. Whether it’s apparel, accessories, or other favorites, you’ll get a meaningful piece that connects you to our mission.
Every purchase of the $50 Mystery Box directly supports Sky Foundation, a nonprofit dedicated to raising awareness and funding innovative research for pancreatic cancer. That means your surprise item carries more than just value—it represents hope for patients, families, and researchers working toward a cure.
Monthly giving has never been easier or more fun. By choosing this box, you’re partnering with Sky Foundation in a tangible way while enjoying a thoughtful mystery gift that arrives at your door. Each box is a reminder that small acts of generosity can have a big impact in the fight against pancreatic cancer.
FAQ Section
Q: What comes in the $50 Mystery Box?
A: Each month, your box will include one surprise item from the Cure Cancer Shop. It could be apparel, accessories, or other store favorites. Every item is thoughtfully chosen and exclusive to this mystery box.
Q: When will I receive my box?
A: Boxes are shipped monthly and typically arrive within 5–7 business days after shipping. You’ll receive tracking information as soon as your order is on its way.
Q: How does my purchase help Sky Foundation?
A: Each $50 Mystery Box directly funds Sky Foundation, a nonprofit focused on pancreatic cancer awareness and research. Your subscription turns a surprise gift into meaningful support.
Share

Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...